AXIM Biotechnologies, Inc. (OTCMKTS:AXIM) Short Interest Update

AXIM Biotechnologies, Inc. (OTCMKTS:AXIM) was the target of a significant decrease in short interest during the month of September. As of September 30th, there was short interest totalling 5,500 shares, a decrease of 96.8% from the September 15th total of 172,600 shares. Based on an average trading volume of 1,441,100 shares, the short-interest ratio is currently 0.0 days.

AXIM Biotechnologies Stock Performance

Shares of OTCMKTS:AXIM opened at $0.00 on Friday. The firm’s 50 day moving average is $0.01 and its two-hundred day moving average is $0.01. AXIM Biotechnologies has a 52 week low of $0.00 and a 52 week high of $0.02.

AXIM Biotechnologies Company Profile

AXIM Biotechnologies, Inc engages in the development and sale of diagnostic healthcare solutions in the areas of SARS-CoV-2, eye health, and other diseases. The company is developing tests for dye eye diseases; SARS-CoV-2 neutralizing antibody tests; and fentanyl neutralizing antibody tests. It also developing a line of novel diagnostics for early cancer detection, response to treatment, and recurrence monitoring.